Abstract
BackgroundTocilizumab is a humanized anti-human IL-6 receptor monoclonal antibody that has been demonstrated to improve RA symptoms. However, it remains unclear whether the use of tocilizumab constitutes an independent risk...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
